Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-METHOXYPHENYL)CYCLOBUTANAMINE HCL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1228879-06-8

Post Buying Request

1228879-06-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1228879-06-8 Usage

Chemical class

Cyclobutylamines

Structural features

Contains a cyclobutane ring
Substituted with a 4-methoxyphenyl group
Contains an amine group

Salt form

Hydrochloride (HCl)
Enhances stability and solubility

Potential applications

Psychoactive agent
Pharmaceutical agent

Research status

Further research needed to fully understand its properties and potential uses
Please note that this list is based on the limited information provided in the material. Additional research and data may reveal more properties and specific content related to 1-(4-METHOXYPHENYL)CYCLOBUTANAMINE HCL.

Check Digit Verification of cas no

The CAS Registry Mumber 1228879-06-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,8,7 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1228879-06:
(9*1)+(8*2)+(7*2)+(6*8)+(5*8)+(4*7)+(3*9)+(2*0)+(1*6)=188
188 % 10 = 8
So 1228879-06-8 is a valid CAS Registry Number.

1228879-06-8Downstream Products

1228879-06-8Relevant academic research and scientific papers

Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same

-

Paragraph 0286; 0293-0295, (2017/07/18)

The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1228879-06-8